Rare disease
Rare disease
Championing innovation in rare disease by partnering with patient communities
Leverage our specialist networks who will draw on their combined expertise in medical strategy, market access and regulatory documents to make your limited resources count.
In rare disease, patient populations are small, tightly knit and often underserved. Though products may be approved quickly, patients can struggle to access the treatments they need.
From centres of excellence, patient advocacy groups to digital influencers, a partnership approach in rare disease is critical. We help you better understand rare disease communities and authentically engage with them.
By combining specialist rare disease knowledge with tech-enabled insights, we provide guidance on which stakeholders you most need to partner with and where you can bring most value to them.
Deep rare disease expertise
Our multidisciplinary network of rare disease specialists use their skills across strategy, engagement, communications, market access and regulatory writing to support with critical activities, including:
More than 15 years’ partnering with rare disease communities
>75% PHDs, MScs and higher scientific qualifications
Multidisciplinary insight engine
Supporting in haemophilia and rare bleeding disorders, we mapped patient pathways and identified centres of excellence, as well as developing symposia with multidisciplinary healthcare professionals and patients. We supported a webinar aiming to improve diagnosis through targeting clinical specialties not usually involved in the care of rare bleeding disorders:
A breadth of capabilities
By combining global cross-functional working, specialist knowledge and tech-enabled insights, we help our clients streamline their scientific strategy and enhance patient access.